Intelligent Bio Solutions Inc. (INBS) vs VolitionRX Limited (VNRX)

Intelligent Bio Solutions Inc. and VolitionRX Limited are both Medical Devices companies. Intelligent Bio Solutions Inc. and VolitionRX Limited are of similar size ($5.3M and $4.8M). VolitionRX Limited grew revenue faster over the last twelve months: 86.3% against 38.1%. Intelligent Bio Solutions Inc. has the higher net margin (−294.9% vs −1,043.1%) and the lower return on invested capital (−606.9% vs 0.00%). Across the 17 metrics below, Intelligent Bio Solutions Inc. leads on 10 and VolitionRX Limited on 7.

Valuation

Metric INBS VNRX Medical Devices median
P/E n/m n/m 23.22
P/S 0.52 0.67 2.34
P/B 0.42 n/m 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 0.15 4.01 2.24
Earnings yield (601.33%) (2,122.22%) (10.09%)
Free cash flow yield (553.24%) (1,206.46%) (8.47%)

Profitability

Metric INBS VNRX Medical Devices median
Gross margin 48.64% 100.00% 56.01%
Operating margin (299.11%) (790.20%) (15.03%)
Net margin (294.91%) (1,043.08%) (20.40%)
Free cash flow margin (289.93%) (796.73%) (7.24%)
Return on equity (306.76%) 76.95% (15.32%)
Return on assets (123.13%) (301.54%) (19.72%)
Return on invested capital (606.86%) 0.00% (10.33%)

Growth

Metric INBS VNRX Medical Devices median
Revenue growth (TTM) 38.09% 86.32% 8.80%
EPS growth (last fiscal year) 57.80% 29.03% 29.03%
Revenue growth, 5-year CAGR 16.31% 164.28% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INBS VNRX Medical Devices median
Debt to equity 0.00 (0.33) 0.07
Current ratio 1.44 0.30 2.50
Net debt to EBITDA 0.35 (0.52) 0.49

Dividend

Metric INBS VNRX Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric INBS VNRX Medical Devices median
Market cap 4.78m 5.25m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack